Day: November 21, 2023

SCOTTSDALE, Ariz., Nov. 21, 2023 (GLOBE NEWSWIRE) — CISO Global (NASDAQCM: CISO) has been designated a Top 250 Managed Security Services Provider by cybersecurity business intelligence company CyberRisk Alliance and MSSP Alert, the authoritative news and research channel for managed security services providers (MSSPs). CISO Global ranked 25th on this year’s international list of Top 250 MSSPs, solidifying the company’s status as an industry leading MSSP. “MSSP Alert and CyberRisk Alliance congratulate CISO Global for its inaugural appearance on the list,” said Jessica C. Davis, editorial director of MSSP Alert, a CyberRisk Alliance resource. “The Top 250 MSSPs are an impressive group of companies that continue to outperform the overall cybersecurity services market in 2023. It’s an indication of the strength of managed security...

Customers used 79.3 TB of data over Verizon’s fast, reliable 5G Ultra Wideband network. Network Slicing demo showed exceptional performance for streaming content in a high data-usage environment. LAS VEGAS, Nov. 21, 2023 (GLOBE NEWSWIRE) — Verizon customers who attended the big motorsports event in Las Vegas had a lot to celebrate this past weekend. More than 100,000 fans attending the multiple day event used Verizon’s wireless network to share their racing experiences quickly and reliably. Verizon customers used 79.3 TB of data throughout the event, the equivalent of streaming a feature length movie almost 22,000 times. “Our 5G Ultra Wideband network is built specifically to manage crowded events, providing reliability and massive capacity so customers can capture, share and connect throughout the experience,” said Phillip French,...

November 21, 2023 SBM Offshore reports that it has completed the repurchase of 350,000 shares. Between November 9, 2023 and November 21, 2023 a total of 350,000 common shares were repurchased, at an average price of EUR 12.25 per share, representing a total of EUR 4,286,956. Information regarding the aggregate of the transactions (calculated on a daily basis) for the period in which the program was executed can be found in the top half of the table below. Further detailed information regarding all individual transactions can be accessed via the Investor Relations section of the Company’s website. The repurchases were made under the program announced on and effective from November 9, 2023. The objective of the program was to meet obligations from regular management and employee share programs.  Final Period Share Repurchase Program Transaction...

VANCOUVER, British Columbia, Nov. 21, 2023 (GLOBE NEWSWIRE) — NINE MILE METALS LTD. (CSE: NINE, OTCQB: VMSXF, FSE: KQ9) (the “Company” or “Nine Mile”), announces its intention to complete an unsecured loan financing for proceeds of up to $500,000 (the “Loan”) for accredited investors. The Loan will have a term of 12 months from the closing (the “Maturity Date”), and bear interest at 12 per cent per annum, calculated and payable on the Maturity Date. In consideration for the Loan, the Company has agreed to issue a 20% bonus in common shares of the Company (the “Bonus Shares”). The calculation of the Bonus Shares will be 20% of the principal amount of the Loan divided by $0.11 per share. The Bonus Shares will be subject to a four month and a day hold period. Loan proceeds will be used for advancing the bulk study program on Nine...

Funding provided by Nice & Green SA, a Swiss private investor This CB Program supersedes the previous one To extend its cash runway and continue the ongoing clinical trials in CNS and oncology Initial execution of €8 million in two tranches of €4 million each, plus optional additional tranches of up to €5 million each to be executed in the future, at Oryzon’s request, subject to customary conditionsMADRID, Spain and BOSTON, Nov. 21, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today the entry into a new convertible bonds financing agreement with Nice & Green in bonds convertible into new shares for a total amount of €45 Million. The financing...

TUCSON, AZ, Nov. 21, 2023 (GLOBE NEWSWIRE) — Liberty Star Minerals (“Liberty Star” or the “Company”) (OTCMarkets: LBSR) announces that it has engaged NISS Drilling Services to undertake diamond core drilling at Liberty Star’s Red Rock Canyon Gold Project (RRC) within the larger Hay Mountain Project (HMP) in southeast Arizona. Drilling is also planned at HMP Target 1 near the RRC. While the emphasis at Red Rock Canyon is gold exploration, both project areas may possess commercially important metals including rare earth minerals which are associated with porphyry copper-gold-moly bodies, and are well represented in the area from central Arizona to northern Mexico. The planned program consists of diamond core drilling of about 250 feet per hole within the RRC at or near historic drill sites previously drilled and logged for the presence...

   Ageas provides business update at the Investor Day in London Today, Ageas held its Investor Day at which the Group provided an update on its Impact24 strategy, its performance, and other selected topics. Ageas confirms Group commitments Ageas reconfirmed its guidance for the 2023 net operating result to reach the upper end of the EUR 1.1 to 1.2 billion range, even taking into account the recent storms in Belgium, the UK and France. The Group also re-iterated its confidence in the operating entities’ ability to upstream more than sufficient cash to deliver on the Group’s DPS growth target of 6 to 10% set under Impact24. The Group’s solid foundation assures an attractive dividend growth in line with the Impact24 ambition also beyond this strategic cycle. Continued growth potential in China The business in Asia, and more specifically...

PORTLAND, Maine, Nov. 21, 2023 (GLOBE NEWSWIRE) — Verizon announces a $100,000 award to the Portland Regional Chamber of Commerce (“the Chamber”) for the development of Opportunity Clicks. The partnership is part of the Verizon Forward Community Enhancement Award, a $1 million national initiative equipping communities with the tools to navigate an increasingly technological world. Through Opportunity Clicks, the Chamber will partner with give IT. get IT., Maine’s only nonprofit computer access and digital literacy program. Together, they will provide low-income households with refurbished computers and free training to pursue academic and career goals necessary to join the regional workforce. The Chamber serves more than 1,400 member businesses in eight communities in Greater Portland, ranging from sole proprietorships to the state’s...

Planegg/Martinsried, November 21, 2023 The Executive Management Board of Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today adjusted financial guidance for fiscal year 2023. The Company maintains its guidance on expected revenues to be between EUR 5 and 7 million in 2023 (unchanged). The Company continuously optimizes its resource allocation based on business demands. Due to the challenging capital markets environment, the Company focuses on careful cost management and resource allocation. Based on the strategic prioritization of its portfolio together with an optimization of its resource allocation, the Company expects to extend its cash runway into the first quarter of 2025 (previously fourth...

No severe adverse events reported to date Topline data expected as early as Q1 2024 OCALA, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the last subject has completed treatment in the Company’s Phase 2 study evaluating Ampligen® as a potential therapeutic for people with the Post-COVID condition of fatigue (“AMP-518”). AIM Chief Executive Officer Thomas K. Equels commented, “With dosing now complete, our AMP-518 focus turns to the next milestone of being able to report topline study data as soon as it is available. We continue to believe in the potential of Ampligen to provide a much-needed therapeutic option to treat Long COVID with chronic fatigue-like symptoms. Post-COVID conditions have emerged as a serious public health threat and a clear public need.” As...